Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-TT vs Mencevax ACWY in Healthy Subjects
NCT00356369Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of meningococcal group A, C, W135 and Y conjugate vaccine in meningococcal disease, sponsored by GSK. Started Dec 2006; status: completed.
02
Drugs
meningococcal group A, C, W135 and Y conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on NCT00356369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356369.